What's breaking now, across thousands of outlets.
(RTTNews) - Eisai Co. (4523.T, EII.SG) and Biogen (BIIB) announced that once weekly lecanemab-irmb subcutaneous injection - LEQEMBI IQLIK - is now available in the U.S. for initiation therapy for early Alzheimer's disease in adults with mild cognitive impairment or mild dementia
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
Peter Mac researchers have identified potential new drug targets for pancreatic cancer by uncovering proteins cancer cells rely on to grow and survive.
What if the device keeping your heart beating was entirely man-made? Inside a high-precision manufacturing facility in Singapore, trained mostly women operators sit behind microscopes, carefully…
<p>Doha, Qatar: With the start of the new academic year fast approaching, the Ministry of Municipality has shared a set of guidelines aimed at promoting a safe, healthy and sustainable school…
One of Ben Wong's clients is an elderly man who shunned others after his dog died. "At his home, there were only some instant noodles and alcohol," Wong spoke about his client's sense of isolation.
One of Ben Wong's clients is an elderly man who shunned others after his dog died. "At his home, there were only some instant noodles and alcohol," Wong spoke about his client's sense of isolation.
